Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients.
第一作者:
Dominic,McGrosso
第一单位:
Department of Pharmacology, University of California, San Diego, La Jolla, CA, United States.;Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States.
作者:
医学主题词
人类(Humans);免疫球蛋白类, 静脉内(Immunoglobulins, Intravenous);补体系统蛋白质类(Complement System Proteins);血液凝固(Blood Coagulation);中年人(Middle Aged);男(雄)性(Male);女(雌)性(Female);蛋白质组学(Proteomics);老年人(Aged);补体激活(Complement Activation);成年人(Adult);治疗结果(Treatment Outcome)
DOI
10.3389/fimmu.2025.1623309
PMID
40821834
发布时间
2025-09-11
- 浏览1
Frontiers in immunology
1623309页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



